BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221026
DTEND;VALUE=DATE:20221027
DTSTAMP:20220921T211348Z
CREATED:20220921T211237Z
LAST-MODIFIED:20220921T211348Z
UID:56442-1666742400-1666828799@globalbiodefense.com
SUMMARY:In-Depth Look at Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs
DESCRIPTION:The FDA will host a meeting on 26 October 2022 to provide additional clarity to the final guidance with respect to Agency expectations for submissions containing Bioavailability information for drug products\, and will discuss: \n\nSelect case studies on various bioavailability (BA) related subtopics (e.g. pharmacodynamic (PD) endpoints\, endogenous compound Narrow Therapeutic Index (NTI)\, biowaivers).\nBioavailability Studies Submitted in NDAs and INDs – General Considerations\nBioavailability Determination: Special Topics\nRelative Bioavailability Evaluation: Potential for Using Pharmacodynamic and Non-Traditional Pharmacokinetic Endpoints\nRecommended In Vitro Studies\n\nThe intended audience for this event is: Regulatory Scientists assessing bioavailability studies as part of IND/NDA/BLA submissions; Research Coordinators overseeing in vivo studies in the context of IND/NDA/BLA submissions; Drug Development/New Drug industry scientists involved with bioavailability studies for support of a new/existing IND/NDA/BLA dossier; and foreign regulators. \nPlease visit the FDA’s In-Depth Look at BA Final Guidance Meeting website to register. \nFDA RESOURCES\nFinal Guidance for Industry: Bioavailability Studies Submitted in NDAs or INDs — General Considerations
URL:https://globalbiodefense.com/event/in-depth-look-at-final-fda-guidance-bioavailability-studies-submitted-in-ndas-or-inds/
CATEGORIES:Continuing Education,Government Hosted
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221011
DTEND;VALUE=DATE:20221012
DTSTAMP:20220921T200930Z
CREATED:20220921T200613Z
LAST-MODIFIED:20220921T200930Z
UID:56431-1665446400-1665532799@globalbiodefense.com
SUMMARY:FDA NanoDay Symposium 2022
DESCRIPTION:The FDA NanoDay Symposium 2022 will be held on 11 October 2022. The event will address drug development of products that contain nanomaterials in their formulation and how the newly finalized guidance to industry for products that contain nanomaterials can be implemented in filings to the FDA. \nHighlighted topic areas include: \n\nPrimary Chemistry Manufacturing and Controls (CMC) and nonclinical hurdles for developing products that contain nanomaterials\nDevelopment and Characterization of Generic Drug Products Containing Nanomaterials\nConsiderations for the Quality\, Safety and Efficacy of Prophylactic Lipid Nanoparticle mRNA Vaccines\nCase studies on the development of the COVID mRNA lipid nanoparticle vaccine products\nFuture of Continuous Manufacturing of Drug Products Containing Nanomaterials\nEfforts to establish standards and standard methods for monitoring products that contain nanomaterials\nA contextualized discussion of the development of the COVID mRNA lipid nanoparticle vaccine products\nA nonclinical perspective of developmental challenges of products that contain nanomaterials\nSafety Evaluation of Food Contact Substances Containing Nanomaterials\n\nThe intended audience includes: Regulatory science and regulatory affairs professionals working on drug products\, including biologicals\, that contain nanomaterials and submit IND/NDA/BLA/ANDA applications for FDA review; researchers working on applications of nanotechnology for pharmaceutical products\, analytical methodology for control of pharmaceuticals that contain nanomaterials\, and nonclinical studies to support human clinical trials; and foreign regulators who review comparable pharmaceutical products that contain nanomaterials. \nPlease visit the FDA’s NanoDay Symposium 2022 website for more information. \nFDA RESOURCES\n\nGUIDANCE DOCUMENT: Drug Products\, Including Biological Products\, that Contain Nanomaterials – Guidance for Industry; APRIL 2022\nGUIDANCE DOCUMENT: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology – Guidance for Industry; JUNE 2014\nGUIDANCE DOCUMENT: Liposome Drug Products: Chemistry\, Manufacturing\, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation; APRIL 2018\nGUIDANCE DOCUMENT: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs\, Including Well-Characterized\, Therapeutic\, Biotechnology-derived Products – Guidance for Industry; NOVEMBER 1995
URL:https://globalbiodefense.com/event/fda-nanoday-symposium-2022/
CATEGORIES:Continuing Education,Government Hosted
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210924T094500
DTEND;TZID=America/New_York:20210924T160000
DTSTAMP:20210812T195235Z
CREATED:20210812T195020Z
LAST-MODIFIED:20210812T195235Z
UID:49495-1632476700-1632499200@globalbiodefense.com
SUMMARY:Review of Third-Party Research Risk: Is There a Role for IRBs?
DESCRIPTION:“Review of Third-Party Research Risk: Is There a Role for IRBs?\,” an HHS Office for Human Research Protections (OHRP) Exploratory workshop\, will be livecast on 24 September 2021. \nThe research community has generally focused on the protection of human research subjects as defined by the\nCommon Rule. However\, sometimes the conduct of research can have an impact on people who are third parties\nand who do not meet the definition of human subjects. This meeting will explore who some of the impacted parties are and what types of risks they might face in various types of research. It will further explore the idea of expanding regulatory protections to cover third parties in some circumstances. Panelists will discuss whether and what support for this idea already exists in the field of research ethics and whether institutional review boards (IRBs) have a role to play in oversight of such protections should they be warranted. \nHighlighted sessions include: \n\nPanelists will consider whether researchers and the research community have a responsibility to protect third parties and if so\, in what capacity.\nResearch Studies That Do Not Directly Involve Human Subjects\nThird-Party Risk in Clinical Research Trials\nEnsuring Privacy\, Building Trust: Collecting\, Processing\, and Sharing Third-Party Information in Social\nand Behavioral Health Research\nEthical Considerations for Third-Party Risk in Research\nLimiting Non-Consenting Third Parties to Reasonable Research Risks\nPublic Risk Perception and the Creation of Clear Communications\nReviewing Third-Party Risks: A Proposed Framework for IRBs (and Researchers)\nAre IRBs the Right Oversight Bodies for Protecting Third Parties?\n\nVideos of each session will be available on the HHS OHRP website after the event. All Exploratory Workshop sessions meet the Certified IRB Professional (CIP) recertification guidelines exit disclaimer icon and are eligible for a maximum of 5 hours of credits.
URL:https://globalbiodefense.com/event/review-of-third-party-research-risk-is-there-a-role-for-irbs/
CATEGORIES:Conference,Continuing Education
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/08/ohrp-review-third-party-research-risk-role-irb-clinical-trial-bioethics.jpg
LOCATION:https://videocast.nih.gov/watch=41987
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210308T140000
DTEND;TZID=America/New_York:20210308T153000
DTSTAMP:20210225T234524Z
CREATED:20210225T234524Z
LAST-MODIFIED:20210225T234524Z
UID:48658-1615212000-1615217400@globalbiodefense.com
SUMMARY:TRB Webinar: Visualizing Effects of COVID-19 on Transportation: A One-Year Retrospective
DESCRIPTION:The Transportation Research Board will host a Visualizing Effects of COVID-19 on Transportation: A One-Year Retrospective webinar on March 8\, 2021 that will delve into the pandemic’s effect on transportation. \nPresenters will discuss visualizations of where these impacts have been especially notable\, including the drastic reduction in road and air traffic and in public transit ridership during early days of the pandemic. They will provide perspectives from the local\, state\, and international levels. \nHighlighted presentations include: \n\nVisualizing COVID-19 impacts on urban mobility: Kaan Ozbay\, New York University\nVisualizing COVID-19 impacts on state level-mobility: Michael Pack\, University of Maryland\nVisualizing COVID-19 impacts on air travel: Mark Duell\, FlightAware\nQuestion and answer session: Charles Lattimer\, University of Maryland\n\nThe first 60 minutes of the webinar will be for presentations and the final 30 minutes will be reserved for audience questions. \nProfessional Development Hour Information \nProfessional engineers (PEs) who register and attend the entire webinar as an individual will be awarded 1.5 Professional Development Hours (PDHs). TRB’s webinar program awards PDH credits only to the registered individual\, and not to other members of a group that view the webinar together. To be eligible for the credits\, individuals must remain signed in for the entire webinar\, including for any question and answer session following the presentations. \nThis webinar was organized by the TRB Standing Committee on Visualization in Transportation. \nLearn more at the National Academies’ Visualizing Effects of COVID-19 on Transportation: A One-Year Retrospective webpage. \n 
URL:https://globalbiodefense.com/event/trb-webinar-visualizing-effects-of-covid-19-on-transportation-a-one-year-retrospective/
CATEGORIES:Continuing Education,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201016T130000
DTEND;TZID=America/New_York:20201016T150000
DTSTAMP:20200923T001907Z
CREATED:20200923T001702Z
LAST-MODIFIED:20200923T001907Z
UID:47174-1602853200-1602860400@globalbiodefense.com
SUMMARY:Pediatric Perspectives During a Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘Pediatric Perspectives During a Pandemic” on 16 October 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the epidemiology of acute COVID-19\, including post-infectious manifestations and the unique aspects of caring for children during a pandemic. NETEC will also discuss the features of MIS-C and how to devise a diagnostic and acute management plan and integrate potential post-recovery complications into the development of follow-up plans for a child with MIS-C. \nRegister for the event here: http://bit.ly/netec-pediatric-pandemic
URL:https://globalbiodefense.com/event/pediatric-perspectives-during-a-pandemic/
CATEGORIES:Continuing Education,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200925T130000
DTEND;TZID=America/New_York:20200925T150000
DTSTAMP:20200922T225747Z
CREATED:20200922T225650Z
LAST-MODIFIED:20200922T225747Z
UID:47168-1601038800-1601046000@globalbiodefense.com
SUMMARY:COVID-19: Current State of the Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘COVID-19: Current State of the Pandemic” on 25 September 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the current pandemic hotspots in the US and globally\, including the epidemiology of the current wave of infections; discuss country-wide testing needs to mitigate and suppress COVID-19 infections; and review the evidence regarding possible re-infections of COVID-19\, and interpret the data behind the newest therapeutic guidelines for COVID-19. \nRegister here to attend the virtual event.
URL:https://globalbiodefense.com/event/covid-19-current-state-of-the-pandemic/
CATEGORIES:Conference,Continuing Education
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191120
DTEND;VALUE=DATE:20191125
DTSTAMP:20190927T174635Z
CREATED:20190907T232320Z
LAST-MODIFIED:20190927T174635Z
UID:30286-1574208000-1574639999@globalbiodefense.com
SUMMARY:ASTMH 2019 - American Society of Tropical Medicine and Hygiene
DESCRIPTION:The American Society of Tropical Medicine and Hygiene will host the 2019 ASTMH Annual Meeting on 20-24 November 2019 in National Harbor\, Maryland. \nThis 5-day five-day educational conference that includes four pre-meeting courses draws approximately 4\,800 tropical medicine and global health professionals representing academia\, government\, non-profits\, philanthropy\, NGOs\, industry\, military and private practice. \nThe meeting is designed for researchers\, professors\, government and public health officials\, military personnel\, travel clinic physicians\, practicing physicians in tropical medicine\, students and all health care providers working in the fields of tropical medicine\, hygiene and global health. \n \nThis year’s pre-meeting courses include: \n\nTropical Diseases Encountered in Non-Travel Clinics (Clinical Group)\nImaging Parasites from Single Molecules to Entire Organsims (Parasitology)\nArboviromics: How ‘omics’ Technologies are Advancing Arbovirus Research\nand Control (Arbovirology)\nField Applications for Stopping Infectious Disease Threats at International\nPoints of Entry (Global Health)\n\nPlease visit the ASTMH Annual Meeting website for more information: http://bit.ly/ASTMH2019TropMed
URL:https://globalbiodefense.com/event/astmh-annual-meeting-2019/
LOCATION:Gaylord National Resort and Convention Center\, 201 Waterfront Street\, National Harbor\, MD\, 20745\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191102
DTEND;VALUE=DATE:20191107
DTSTAMP:20190927T170437Z
CREATED:20190927T165804Z
LAST-MODIFIED:20190927T170437Z
UID:30689-1572652800-1573084799@globalbiodefense.com
SUMMARY:APHA 2019 Annual Meeting and Expo
DESCRIPTION:The American Public Health Association will host the APHA 2019 Annual Meeting and Expo on 2-6 Nov 2019 in Philadelphia\, Pennsylvania. \nJoin nearly 13\,000 public health colleagues at APHA 2019 for an extensive lineup of Continuing Education learning sessions and a Public Health Expo. \nSession topics of interest highlighted by the Global Biodefense staff include: \n\nNursing student willingness to respond to high-consequence infectious disease outbreaks\nCollaboration Across three nations for improved infectious disease surveillance\nInfectious disease agents of zoonotic potential of healthy horses in an exhibition setting\nComparing vector and human surveillance strategies to detect arbovirus transmission\nPublic health implications of veterinary telemedicine\nNeisseria meningitidis in Houston\, TX: 3-year data\nAssessing the Impact of ehealth ssage on seasonal influenza vaccine uptake in adults\nMajor challenges for successful hepatitis B vaccination in low resource settings\nEstimation of infectious disease dynamics: Application of a recurrent neural network\nIntersection of Race\, Gender and Vaccination Uptake during the 2009 H1N1 Influenza Pandemic\nAssessing the global prevalence of CYP2D6 haplotype variation\, and the implications for primaquine distribution and Plasmodium vivax control\nEnhancing the informatics response to the Zika epidemic in Puerto Rico: A case study to improve laboratory testing capacity and information management processes\nCross sectional study of employment status of recent physician graduates in the Democratic Republic of Congo\nMotivations and barriers associated with physician volunteerism for an International Telemedicine Organization\nA case report of acute flaccid paralysis associated with arboviruses infection in Panama\nEffect of land use\, land cover\, and climate change on the incidence and outbreak of Japanese Encephalitis disease among Asian population\nRole of gender and socioeconomic status as risk factors for emerging infectious disease transmission in Bangladesh\nDetection of infectious disease agents from the respiratory tract and conjunctiva of cats within animal shelters in the United States\nA comparison of common environmental and demographic associations across multiple tick-borne diseases in the United States\nAdaptation of the One Health Zoonotic Disease Prioritization Tool\n\nPlease visit the APHA 2019 website for more information. \n 
URL:https://globalbiodefense.com/event/apha-2019-annual-meeting-and-expo/
LOCATION:Pennsylvania Convention Center\, 1101 Arch St.\, Philadelphia\, PA\, 19107\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191002
DTEND;VALUE=DATE:20191007
DTSTAMP:20190812T143115Z
CREATED:20190812T142839Z
LAST-MODIFIED:20190812T143115Z
UID:29965-1569974400-1570406399@globalbiodefense.com
SUMMARY:IDWeek 2019
DESCRIPTION:IDWeek 2019\, the combined annual meeting of IDSA\, SHEA\, HIVMA\, and PIDS\, will be held 2-6 October 2019 in Washington\, DC. \nIDWeek is geared toward healthcare professionals in infectious diseases and healthcare epidemiology and prevention\, including researchers\, clinicians\, quality and patient safety practitioners\, epidemiologists\, and public health officials. \nAgenda topics of interest highlighted by the Global Biodefense staff include: \n\nOutbreak Response in the Genomic and Information Age\nHow Genomics is Revolutionizing Biomedicine Across Disciplines\, Across Continents\nUS Measles Outbreak: Summary of US Epi Data in General and Specific NYC Outbreak\nChallenging Cases in Pediatric Infectious Diseases\nThe Next Generation of ID Host Response Biomarkers\nFDA Perspective on Metagenomic Sequencing in Infectious Diseases\nProcalcitonin and Common Febrile Illnesses: Hype or Help?\nWhat’s New in the Field of Clinical and Epidemiological Sciences\nLatent TB in the US\nDisplaced: Infectious Disease Impacts on Refugee and Migrant Populations\nThe Ideal Infection Prevention Hospital: Air Handling\nUpdates on Interferon-Gamma Release Assay Performance\nCyclospora: Epidemiology\, Diagnosis and Treatment\nAuthophagy and Autophagy-Related Pathways in Host Defense\nInnate Lymphocytes and Trained Immunity\nInfluenza Vaccines: Are We Ready for Different Vaccines for Different Populations?\nThe Rationale for Using Phages as Therapeutic Weapons\nPhage Lysins Effectively Target MDR ESKAPE Pathogens\nTargeting Contact Precautions: It’s About the Pathogen\nRapid Diagnostics and Resistance: Accelerate\, BacterioScan\, Klaris\, LifeScale\, Roche\, Selux\, Specific Diagnostics\nAntenatal Zika Virus Exposure\nAcute Flaccid Myelitis – National Perspective\n\nPlease visit the IDWeek 2019 website to register.
URL:https://globalbiodefense.com/event/idweek-2019/
LOCATION:Walter E. Washington Convention Center\,  801 Mt Vernon Pl NW\, Washington\, DC\, 20001\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190508
DTEND;VALUE=DATE:20190512
DTSTAMP:20190501T170200Z
CREATED:20190216T054737Z
LAST-MODIFIED:20190501T170200Z
UID:23606-1557273600-1557619199@globalbiodefense.com
SUMMARY:MAD-ID 2019: Making a Difference in Infectious Diseases
DESCRIPTION:The 22nd Annual MAD-ID Meeting will be held in Orlando\, Florida\, May 8-11\, 2019. \nPharmacists physicians\, nurses and other providers will be given the opportunity to participate in a 3-day educational symposium specifically designed to apply recent research to patient care and antimicrobial stewardship. \nHighlighted sessions include: \n\nThe AMR Challenge: How to Meet the Challenge at Your Institutions\nNew Tests and Technologies for the Microbiology Steward\nPoint of Care Diagnostic Testing\, the Next Frontier for ASPs\nNew Gram-Negative Agents\, Gram-Positive Agents\nOptimizing therapy for Gram-Negative Bacteremia\nShort Course Therapy for Common Infections\nThe Expanding the Antibiotic Pipeline\nBehavior Change Interventions to Improve Outcomes\nPractical Interventions with the Micro Lab\nFormulary Management Strategies in Antimicrobial Stewardship\n\nMAD-ID is an approved provider of continuing pharmacy education and automatically reports to the National Association of Boards of Pharmacy via CPE Monitor.
URL:https://globalbiodefense.com/event/mad-id-2019-making-a-difference-in-infectious-diseases/
LOCATION:Rosen Centre Hotel\, 9840 International Drive\, Orlando\, FL\, 32819\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190429
DTEND;VALUE=DATE:20190503
DTSTAMP:20190501T164018Z
CREATED:20190210T235136Z
LAST-MODIFIED:20190501T164018Z
UID:18348-1556496000-1556841599@globalbiodefense.com
SUMMARY:EIS 2019 - CDC Epidemic Intelligence Service Conference
DESCRIPTION:CDC’s 68th annual Epidemic Intelligence Service conference starts April 29. Join CDC disease detectives\, alumni\, and the public health community to learn about leading-edge public health investigations. \nThe annual EIS conference is the nation’s premier epidemiology conference where EIS officers share their work in leading-edge investigations\, scientific findings\, and forward-thinking strategies to inform improvements in public health—all while gaining valuable presentation experience. EIS officers engage in professional networking sessions\, recognition ceremonies and various learning opportunities. \nFree and open to the public\, this conference draws a diverse attention each year from various public health sectors around the world—from epidemiology and laboratory science sleuths and public health organizations to EIS alumni\, news media\, and prospective applicants. \nWhen a killer bacterium unleashes an outbreak on a beach town\, unlikely partners work to find the water source. Hear more about this and other topics in live streamed TED-style talks at the 68th Annual Epidemic Intelligence Service Conference. https://bit.ly/2Geb3CcExternal \nPlease visit the CDC’s Epidemic Intelligence Service Conference for more information.
URL:https://globalbiodefense.com/event/eis-2019-cdc-epidemic-intelligence-service-conference/
LOCATION:Sheraton Atlanta Hotel\, 165 Courtland St NE\, Atlanta\, GA\, 30303\, United States
CATEGORIES:Conference,Continuing Education
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/eis-2019-promote-1200x675.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190331
DTEND;VALUE=DATE:20190404
DTSTAMP:20190308T184225Z
CREATED:20190107T215715Z
LAST-MODIFIED:20190308T184225Z
UID:20720-1553990400-1554335999@globalbiodefense.com
SUMMARY:SAFMLS at the CLMA KnowledgeLab 2019
DESCRIPTION:Members of the Society of American Federal Medical Laboratory Scientists (SAFMLS)\, formerly known as the Society of Armed Forces Medical Laboratory Scientists\, will attend the CLMA KnowledgeLab 2019 on March 31 – April 3\, 2019 in Grapevine\, Texas. \nMore than 1\,000 laboratory professionals will gather for a wide variety of general session presentations\, pre-conference workshops and educational breakout sessions available the event. This year’s conference features more education than ever before\, with the opportunity to earn up to 25 CEUs. \nKeynote sessions and workshops include: \n\nClinical Lab 2.0: What is it? How Does This Translate into Laboratory Management and Leadership?\nMHS GENESIS: The New DoD Electronic Health Record\nDLM Exam Preparatory Course\nUsing Data Wisely: Informatics for Laboratory Professionals\nLeadership Essentials: What You Need to Know to Grow\n\nA partial list of participating exhibitors includes: \n\nAbbott Laboratories\nAdvanced Instruments\, Inc.\nAerocom Healthcare\nAmerican Medical Technologists\nAmerican Proficiency Institute\nAMETEK PowerVar\nAUDIT MicroControls\, Inc.\nAureus Medical Group\nBeckman Coulter\, Inc.\nBioFire Defense\nBio-Rad Laboratories\nCAREiQ\nCellaVision\, Inc.\nCleveland Clinic Laboratories\nCLMA\nCollege of American Pathologists\nDenLine Uniforms\, Inc.\nDrucker Diagnostics\nExhibitor Name\nFujirebio U.S.\nGeneral Data Healthcare\, Inc.\nGenesisBPS\nGenial Compliance Systems/Rainbow Scientific\, Inc.\nGFMD\, Ltd.\nGold Standard Diagnostics\nGRIFOLS\nHelmer Scientific\nHemosure\, Inc.\nHenry Schein\, Inc.\nHettich Lab Technology\nInfoMagnetics Technologies Corporation\nInMark Packaging\nInova Diagnostics\nKorchek Technologies\nKurin\, Inc.\nLifePoint Informatics\nLuminex Corporation\nMayo Medical Laboratories\nMedical Courier Elite\nMEDTOX Diagnostics\, Inc.\nOrchard Software Corp.\nOrtho Clinical Diagnostics\nPevco\nRALS Connectivity for POCT\nRees Scientific\nRoche Diagnostics Corporation\nSCC Soft Computer\nSeattle Children’s Hospital – PLUGS Program\nSwisslog Healthcare\nSysmex\nTELCOR\nThe Joint Commission\nThermo Fisher Scientific\nTrinity Biotech\nUniversity of North Dakota School of Medicine\nVanderbilt Pathology Laboratory Services\nVisiun\nWellSky\nWondfo USA Co.\, Ltd.\nWSLH Proficiency Testing\n\nNetwork with colleagues and discover new tactics and technologies for managing your laboratory\, providing high-quality patient care and responding to government regulations and policies. \nPlease visit the CLMA KnowledgeLab 2019 website for more information. \nPlease note: CLMA-SAFMLS Joint Membership is available exclusively to military SAFMLS personnel and includes a yearly membership to both Clinical Laboratory Management Association (CLMA) and the Society of American Federal Medical Laboratory Scientists (SAFMLS). Visit the link for more information.
URL:https://globalbiodefense.com/event/safmls-clma-knowledgelab-2019/
LOCATION:Gaylord Texan Resort\, 1501 Gaylord Trail\, Grapevine\, TX\, 76051\, United States
CATEGORIES:Continuing Education
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/2019-safmls-clma-knowledge-lab.png
ORGANIZER;CN="Clinical Laboratory Management Association (CLMA)":MAILTO:info@clma.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190322
DTSTAMP:20190307T224853Z
CREATED:20181223T202727Z
LAST-MODIFIED:20190307T224853Z
UID:20529-1552867200-1553212799@globalbiodefense.com
SUMMARY:NHPC 2019 - National HIV Prevention Conference
DESCRIPTION:The 2019 National HIV Prevention Conference (NHPC) will be held March 18–21\, 2019 in Atlanta\, Georgia. \nThe National HIV Prevention Conference allows in-person collaboration between researchers and program personnel working in HIV prevention. The conference will bring together more than 3\,000 attendees committed to help refine\, improve and strengthen national and local response to HIV. \nThe theme for NHPC 2019 is “Getting to No New HIV Infections\,” which will highlight dynamic approaches to HIV prevention\, detection and management\, and the critical roles that different communities have in achieving this vision. \nThis four-day conference will include plenary sessions along with oral and poster presentations that highlight new HIV science and program activities. \nPlease visit the following links to register to attend the conference\, register to exhibit at the conference\, request space for the CBO/NGO Village\, and request space for an ancillary meeting. \nPlease visit the NHPC website for updates and conference information.
URL:https://globalbiodefense.com/event/nhpc-2019-national-hiv-prevention-conference/
LOCATION:Hyatt Regency Atlanta\, 265 Peachtree street NE\, Atlanta\, 30303\, United States
CATEGORIES:Continuing Education
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/12/national-hiv-conference-2019-cdc.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190304
DTEND;VALUE=DATE:20190308
DTSTAMP:20190429T044259Z
CREATED:20190210T182051Z
LAST-MODIFIED:20190429T044259Z
UID:19288-1551657600-1552003199@globalbiodefense.com
SUMMARY:CROI 2019 - Conference on Retroviruses and Opportunistic Infection
DESCRIPTION:The 2019 Conference on Retroviruses and Opportunistic Infections (CROI) will be held from March 4 to March 7\, 2019 in Seattle\, Washington. \nThis well-respected conference brings together top basic\, translational\, and clinical researchers from around the world to share the latest studies\, important developments\, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. \nAn extensive speaker agenda and poster sessions will cover topics in scientific areas of: \n\nPathogenesis: Human Studies and Animal Models\nHIV-Associated Tumor Viruses\nHost Immune Responses to Infection\, Vaccines\, and Immunotherapy\nHIV Reservoirs\, Latency\, and All Curative Strategies Including Therapeutic Vaccines\nand Gene Therapy\nNeuropathogenesis and Neurologic Complications\nClinical Pharmacology\nAntiretroviral Therapy: Pre-Clinical Data\, Randomized Trials\, Efficacy and Effectiveness Studies\nHIV Drug Resistance\nHIV Diagnostics\nHepatitis Viruses and Liver Complications\nAIDS-Related Malignancies\nCardiovascular Complications of HIV Infection and Antiretroviral Therapy\nTuberculosis and Other Opportunistic Infections\nMaternal and Fetal HIV\nEpidemiology\nPrevention Interventions\nContraception\, Sexually Transmitted Infections\, and Reproductive Health\nImplementation and Scale-Up of Treatment and Care\nPopulation and Cost Modeling\n\nPlease visit the Conference on Retroviruses and Opportunistic Infections (CROI) website for more information.
URL:https://globalbiodefense.com/event/croi-2019-conference-on-retroviruses-and-opportunistic-infection/
LOCATION:Washington State Convention Center\, 800 Convention Pl\, Seattle\, WA\, 98101\, United States
CATEGORIES:Conference,Continuing Education
ORGANIZER;CN="International Antiviral Society-USA":MAILTO:info@iasusa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190128
DTEND;VALUE=DATE:20190202
DTSTAMP:20190125T021908Z
CREATED:20190125T021908Z
LAST-MODIFIED:20190125T021908Z
UID:21876-1548633600-1549065599@globalbiodefense.com
SUMMARY:BSL-3 Laboratory Training
DESCRIPTION:UC Irvine will host an integrated course for high containment laboratory safety practices 28 Jan – 1 Feb 2019 in Irvine\, CA. \nBSL-3 Laboratory Training is a five-day intensive training for laboratory staff\, managers\, biosafety professionals\, and individuals with direct or indirect involvement with work in high-containment. These courses are designed to prepare individuals for the basics of safely working in and around BSL-3 laboratories and includes a mixture of practical and classroom courses covering: \n\nReview of biosafety principles and levels\nRisk assessment and management\nWaste management\nLaboratory management\nSafety procedures\nEmergency management\nBiosafety cabinet practices and procedures\nSmall and large spill decontamination\nDonning and doffing PPE\nLaboratory operations and preventative maintenance\nData and material management\nInventory and records management\nBiosecurity\n\nContact course coordinator for more information: Tran Phan\, 949-824-9536\, bl3train@uci.edu
URL:https://globalbiodefense.com/event/bsl-3-laboratory-training/
LOCATION:UC Irvine BSL-3 Training Center\, 4600 Health Sciences Rd.\, Irvine\, CA\, 92697\, United States
CATEGORIES:Continuing Education,Training
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/bsl-3-uc-irvine-training.png
END:VEVENT
END:VCALENDAR